Helen A Mashek, MD in Newark, DE - Medicare Dermatology

Helen A Mashek, MD is a medicare enrolled "Dermatology" physician in Newark, Delaware. She went to Rutgers New Jersey Medical School and graduated in 1990 and has 34 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice Panzer Dermatology Associates and her current practice location is 537 Stanton Christiana Rd, Suite # 207, Newark, Delaware. You can reach out to her office (for appointments etc.) via phone at (302) 633-7550.

Helen A Mashek is licensed to practice in Delaware (license number C10004790) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1023012515.

Contact Information

	Helen A Mashek, MD
	537 Stanton Christiana Rd, Suite # 207, Newark, DE 19713-2146
	(302) 633-7550
	(302) 633-7556

Physician's Profile

Full Name	Helen A Mashek
Gender	Female
Speciality	Dermatology
Experience	34 Years
Location	537 Stanton Christiana Rd, Newark, Delaware
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Helen A Mashek attended and graduated from Rutgers New Jersey Medical School in 1990

NPI Data:

NPI Number: 1023012515
Provider Enumeration Date: 06/13/2005
Last Update Date: 05/24/2016

Medicare PECOS Information:

PECOS PAC ID: 2466636642
Enrollment ID: I20110413000120

Medical Identifiers

Medical identifiers for Helen A Mashek such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023012515	NPI	-	NPPES
0000709401	Medicaid	DE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	C10004790 (Delaware)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Panzer Dermatology Associates	6103724745	20

News Archive

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.

Drop in breast cancer incidence linked to hormone use, not mammograms

A recent decline in breast cancer incidence is unlikely to be caused by a decrease in mammography screening, according to a study published online August 14 in the Journal of the National Cancer Institute.

Researchers report promising new therapy for recurrent pediatric brain cancers

Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy.

Possible reason for severe side-effects of Northwick Park clinical trial

A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.

Findings have implications for potential gene therapies for autism spectrum disorders

A gene linked to autism spectrum disorders that was manipulated in two lines of transgenic mice produced mature adults with irreversible deficits affecting either learning or social interaction.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Helen A Mashek allows following entities to bill medicare on her behalf.

Entity Name	Panzer Dermatology Associates
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1740201995 PECOS PAC ID: 6103724745 Enrollment ID: O20031222000106

News Archive

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Drop in breast cancer incidence linked to hormone use, not mammograms

Researchers report promising new therapy for recurrent pediatric brain cancers

Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy.

Possible reason for severe side-effects of Northwick Park clinical trial

A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.

Findings have implications for potential gene therapies for autism spectrum disorders

A gene linked to autism spectrum disorders that was manipulated in two lines of transgenic mice produced mature adults with irreversible deficits affecting either learning or social interaction.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Helen A Mashek is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Helen A Mashek, MD 537 Stanton Christiana Rd, Ste 207, Newark, DE 19713-2148 Ph: (302) 633-7550	Helen A Mashek, MD 537 Stanton Christiana Rd, Suite # 207, Newark, DE 19713-2146 Ph: (302) 633-7550

News Archive

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Drop in breast cancer incidence linked to hormone use, not mammograms

Researchers report promising new therapy for recurrent pediatric brain cancers

Two pediatric brain cancers that are challenging to treat if they recur, medulloblastoma and ependymoma, are the target of a clinical trial using a new type of therapy.

Possible reason for severe side-effects of Northwick Park clinical trial

A possible reason why the Northwick Park clinical trial of the drug TGN1412 caused multiple organ failure in human volunteers is revealed in research presented at a conference near Paris.

Findings have implications for potential gene therapies for autism spectrum disorders

A gene linked to autism spectrum disorders that was manipulated in two lines of transgenic mice produced mature adults with irreversible deficits affecting either learning or social interaction.

Dermatology Doctors in Newark, DE

Aton Mordechai Holzer, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 774 Christiana Rd Ste 107, Newark, DE 19713 Phone: 302-230-3376 Fax: 302-224-4990
Dr. Hannah Jean Anderson, MD Dermatology Medicare: Medicare Enrolled Practice Location: 537 Stanton Christiana Rd, Newark, DE 19713 Phone: 302-633-7550
Dr. Matthew Russell Hanson, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 537 Stanton Christiana Road, Siute 107, Apex Medical Center, Newark, DE 19713 Phone: 302-633-7550
Nicole Wotus-silvestri, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 537 Stanton Christiana Rd, Suite 209, Apex Medical Building, Newark, DE 19713 Phone: 302-633-7550 Fax: 302-225-3774
Katrina Pauline Hansen, DO Dermatology Medicare: Medicare Enrolled Practice Location: 774 Christiana Rd Ste 107, Newark, DE 19713 Phone: 302-230-3376
Christopher M Conti, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 537 Stanton Christiana Rd, Suite # 107, Newark, DE 19713 Phone: 302-633-7550 Fax: 302-633-7556

Helen A Mashek, MD - Medicare Dermatology in Newark, DE

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Drop in breast cancer incidence linked to hormone use, not mammograms

Researchers report promising new therapy for recurrent pediatric brain cancers

Possible reason for severe side-effects of Northwick Park clinical trial

Findings have implications for potential gene therapies for autism spectrum disorders

Medicare Reassignments

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Drop in breast cancer incidence linked to hormone use, not mammograms

Researchers report promising new therapy for recurrent pediatric brain cancers

Possible reason for severe side-effects of Northwick Park clinical trial

Findings have implications for potential gene therapies for autism spectrum disorders

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Drop in breast cancer incidence linked to hormone use, not mammograms

Researchers report promising new therapy for recurrent pediatric brain cancers

Possible reason for severe side-effects of Northwick Park clinical trial

Findings have implications for potential gene therapies for autism spectrum disorders

Dermatology Doctors in Newark, DE